Company Filing History:
Years Active: 1990-1993
Title: Innovations by Kouichiro Ishihara
Introduction
Kouichiro Ishihara is a notable inventor based in Hachioji, Japan. He has made significant contributions to the field of medical technology, particularly in the development of therapeutic apparatuses. With a total of 4 patents to his name, Ishihara's work focuses on enhancing treatment methods for various medical conditions.
Latest Patents
Ishihara's latest patents include a "Therapeutical apparatus of extracorporeal type" and an "Extracorporeal ultrasonic lithotripter with a variable focus." The first patent describes a therapeutical apparatus that incorporates a measuring device with a probe capable of generating X-rays or ultrasonic waves. This technology is designed to detect the location of targets such as calculi within the kidney, liver, or biliary ducts. The apparatus also features a therapeutical energy generator that produces shock waves to treat these targets externally. Additionally, it includes structures for moving the generator and measuring apparatus around the patient's surface and activating the generator.
The second patent similarly focuses on a therapeutical apparatus that utilizes a measuring device to locate targets for treatment. It also generates shock waves for therapy and includes mechanisms for displacement and activation, ensuring precise targeting and effective treatment.
Career Highlights
Kouichiro Ishihara is currently associated with Olympus Optical Company, Ltd., where he continues to innovate in the medical technology sector. His work has been instrumental in advancing non-invasive treatment options, making significant impacts on patient care.
Collaborations
Ishihara has collaborated with notable colleagues such as Naoki Uchiyama and Takashi Tsukaya, contributing to the development of advanced medical technologies.
Conclusion
Kouichiro Ishihara's contributions to medical technology through his innovative patents demonstrate his commitment to improving therapeutic methods. His work continues to influence the field, paving the way for future advancements in patient treatment.